{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:56:08Z","timestamp":1788184568960,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.peptides.2005.01.029","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:06:46Z","timestamp":1137697606000},"page":"921-930","source":"Crossref","is-referenced-by-count":87,"title":["Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization"],"prefix":"10.1016","volume":"27","author":[{"given":"Mac E.","family":"Hadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Dorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2005.01.029_bib1","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1021\/jm00132a010","article-title":"Potent and prolonged acting cyclic lactam analogues of \u03b1-melanotropin: design based on molecular dynamics","volume":"32","author":"Al-Obeidi","year":"1989","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2005.01.029_bib2","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1021\/ja00191a044","article-title":"Design of a new class of superpotent cyclic \u03b1-melanotropins based on quenched dynamic stimulations","volume":"111","author":"Al-Obeidi","year":"1991","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.peptides.2005.01.029_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1399-3011.1990.tb00942.x","article-title":"Design, synthesis, and biological activities of a potent and selective \u03b1-melanotropin antagonist","volume":"35","author":"Al-Obeidi","year":"1990","journal-title":"Int J Pept Protein Res"},{"key":"10.1016\/j.peptides.2005.01.029_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1007525117894","article-title":"Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, melanotan-1","volume":"17","author":"Bhardwaj","year":"2000","journal-title":"Pharmaceut Res"},{"key":"10.1016\/j.peptides.2005.01.029_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1523-1747.2001.01224.x","article-title":"Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma","volume":"116","author":"Box","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.peptides.2005.01.029_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0300-483X(93)90140-N","article-title":"Administration of melanotropic peptides during gestation in the rodent","volume":"77","author":"Dawson","year":"1993","journal-title":"Toxicology"},{"key":"10.1016\/j.peptides.2005.01.029_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00173642","article-title":"Toxicologic studies of a superpotent \u03b1-melanotropin, [Nle4,D-Phe7]\u03b1-MSH","volume":"6","author":"Dorr","year":"1988","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.peptides.2005.01.029_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1562\/0031-8655(2000)072<0526:IEEATI>2.0.CO;2","article-title":"Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-\u03b1-MSH in humans","volume":"72","author":"Dorr","year":"2000","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.peptides.2005.01.029_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archderm.140.7.827","article-title":"Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin on human volunteers","volume":"140","author":"Dorr","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.peptides.2005.01.029_bib10","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/0024-3205(96)00160-9","article-title":"Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase I clinical study","volume":"58","author":"Dorr","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/aje\/155.7.614","article-title":"Cutaneous melanin density of Caucasians measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma, and squamous cell carcinoma of the skin","volume":"155","author":"Dwyer","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.peptides.2005.01.029_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00128071-200304060-00004","article-title":"Management of polymorphous light eruptions: clinical course, pathogenesis, diagnosis and intervention","volume":"4","author":"Fesq","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.peptides.2005.01.029_bib13","doi-asserted-by":"crossref","first-page":"15174","DOI":"10.1016\/S0021-9258(18)82452-8","article-title":"Molecular cloning, expression, and gene localization of a fourth melanocortin receptor","volume":"268","author":"Gantz","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2005.01.029_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-0749.1992.tb00540.x","article-title":"Effects of a melanotropic peptide on melanoma cell growth, metastasis, and invasion","volume":"5","author":"Gehlsen","year":"1992","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.peptides.2005.01.029_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1999.tb08662.x","article-title":"The proopiomelanocortin system","volume":"885","author":"Hadley","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0024-3205(87)90047-6","article-title":"Topical application of a melanotropic peptide induces systemic follicular melanogenesis","volume":"40","author":"Hadley","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib17","unstructured":"Hot for the Barbie drug. Time Magazine 2002; August 26:22."},{"key":"10.1016\/j.peptides.2005.01.029_bib18","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/jm00018a005","article-title":"Cyclic lactam \u03b1-melanotropin analogues of Ac-Nle4-c[Asp5,DPhe7,Lys10] \u03b1-MSH4\u201310-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors","volume":"38","author":"Hruby","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2005.01.029_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0749.1995.tb00680.x","article-title":"The melanotropic peptide, [Nle4,D-Phe7]\u03b1-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation","volume":"8","author":"Jiang","year":"1995","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.peptides.2005.01.029_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1749-6632.2003.tb03200.x","article-title":"Significance of the melanocortin-I receptor in regulating human melanocyte pigmentation, proliferation, and survival","volume":"994","author":"Kadekaro","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jnci\/94.3.224","article-title":"Use of tanning devices and risk of basal cell and squamous cell skin cancer","volume":"94","author":"Karagas","year":"2002","journal-title":"JNCI"},{"key":"10.1016\/j.peptides.2005.01.029_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors","volume":"281","author":"Lauman","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.peptides.2005.01.029_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/189176a0","article-title":"Effect of alpha and beta melanocyte stimulating hormones on skin colour of man","volume":"185","author":"Lerner","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2005.01.029_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM196403122701101","article-title":"Melanocyte stimulating hormone and adenocorticotrophic hormone","volume":"270","author":"Lerner","year":"1964","journal-title":"New Engl J Med"},{"key":"10.1016\/j.peptides.2005.01.029_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/09546639909056014","article-title":"Effects of a potent synthetic melanotropin [Nle4-D-Phe7]-\u03b1-MSH (melanotan-I) on tanning: a dose-ranging study","volume":"10","author":"Levine","year":"1999","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.peptides.2005.01.029_bib26","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1001\/jama.266.19.2730","article-title":"Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin","volume":"266","author":"Levine","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.peptides.2005.01.029_bib27","unstructured":"Meyskens Jr., FL. Human melanoma colon formation in soft agar. In: Cloning of Human Tumor Stem Cells, New York, 1980; 85\u201399."},{"key":"10.1016\/j.peptides.2005.01.029_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2003.tb03167.x","article-title":"PT-141: a melanocortin agonist for the treatment of sexual dysfunction","volume":"994","author":"Molinoff","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002800050648","article-title":"Human tumor models in the severe combined immune deficient (scid) mouse","volume":"40","author":"Paine-Murrieta","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.peptides.2005.01.029_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/302711","article-title":"Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype","volume":"66","author":"Palmer","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.peptides.2005.01.029_bib31","unstructured":"Compositions and methods for the diagnosis and treatment of psychogenic erectile dysfunction. US Patent 5,576,290. Issued 6\/24\/94; Inventor: Mac Hadley."},{"issue":"27","key":"10.1016\/j.peptides.2005.01.029_bib32","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1073\/pnas.0400491101","article-title":"Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist","volume":"101","author":"Pfaus","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.peptides.2005.01.029_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1749-6632.1993.tb19749.x","article-title":"Structure activity relationships of LNle4,D-Phe7]\u03b1-MSH: discovery of a tripeptide agonist exhibiting sustained biological activity","volume":"680","author":"Sawyer","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib34","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1073\/pnas.77.10.5754","article-title":"Nle4,D-Phe7]\u03b1-melanocyte-stimulating hormone: a highly potent \u03b1-melanotropin with ultra long biological activity","volume":"77","author":"Sawyer","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2005.01.029_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/icb\/23.3.529","article-title":"\u03b1-Melanocyte stimulating hormone: chemical nature and mechanism of action","volume":"23","author":"Sawyer","year":"1983","journal-title":"Am Zool"},{"key":"10.1016\/j.peptides.2005.01.029_bib36","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1242\/jcs.115.11.2349","article-title":"Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation","volume":"115","author":"Scott","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.peptides.2005.01.029_bib38","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1073\/pnas.172378699","article-title":"A role for the melanocortin 4 receptor in sexual function","volume":"99","author":"Van der Ploeg","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.peptides.2005.01.029_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0022-5347(01)62903-3","article-title":"Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind crossover placebo-controlled study","volume":"160","author":"Wessells","year":"1998","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.peptides.2005.01.029_bib40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0306-4522(02)00866-7","article-title":"Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 induces penile erection via brain spinal melanocortin receptors","volume":"118","author":"Wessells","year":"2003","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.peptides.2005.01.029_bib41","first-page":"574","article-title":"Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with melanotan II","volume":"12","author":"Wessells","year":"2000","journal-title":"Intern J Impotence Res"},{"key":"10.1016\/j.peptides.2005.01.029_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0090-4295(00)00680-4","article-title":"Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction","volume":"56","author":"Wessells","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.peptides.2005.01.029_bib43","unstructured":"Positive data reported on treatment for female sexual dysfunction, September 26, 2002. www.palatin.com."},{"key":"10.1016\/j.peptides.2005.01.029_bib44","unstructured":"Results of Palatin Technologies\u2019 PT-141 phase 2b study in men with erectile dysfunction, May 10, 2004. www.palatin.com."},{"key":"10.1016\/j.peptides.2005.01.029_bib45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.urology.2004.10.060","article-title":"Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response","volume":"65","author":"Diamond","year":"2005","journal-title":"Urology"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105004602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105004602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T21:06:27Z","timestamp":1626987987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978105004602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0196978105004602"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2005.01.029","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}